Emergence of pan-resistance in KPC-2 carbapenemase-producing Klebsiella pneumoniae in Crete, Greece: A close call

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 5, 2016, Pages 1207-1212

  Bathoorn, E ^a   Tsioutis, C ^b   da Silva Voorham, J M ^a   Scoulica, E V ^c   Ioannidou, E ^d   Zhou, K ^a   Rossen, J W ^a   Gikas, A ^b   Friedrich, A W ^a   Grundmann, H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

^d Rethymnon General Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; COTRIMOXAZOLE; BETA LACTAMASE; BETA-LACTAMASE KPC-2, KLEBSIELLA PNEUMONIAE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENETIC BACKGROUND; GREECE; HUMAN; KLEBSIELLA PNEUMONIAE; POINT MUTATION; BACTERIAL GENOME; DNA SEQUENCE; DRUG EFFECTS; ENZYMOLOGY; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIOLOGY; MULTIDRUG RESISTANCE; SECRETION (PROCESS);

BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOME, BACTERIAL; GREECE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; SEQUENCE ANALYSIS, DNA;

EID: 84965031010     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv467     Document Type: Article

References (17)

1. WHO. Antimicrobial Resistance, Global Report on Surveillance. 2014. http:// apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng. pdf?ua=1.
2. Rafailidis PI, Falagas ME. Options for treating carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis 2014; 27: 479-83.
3. Daikos GL, Tsaousi S, Tzouvelekis LS et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 2014; 58: 2322-8.
4. Giakkoupi P, Papagiannitsis CC, Miriagou V et al. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10). J Antimicrob Chemother 2011; 66: 1510-3.
5. Pournaras S, Protonotariou E, Voulgari E et al. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009; 64: 348-52.
6. Souli M, Galani I, Antoniadou A et al. An outbreak of infection due to b-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010; 50: 364-73.
7. Weterings V, Zhou K, Rossen JW et al. An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread. Eur J Clin Microbiol Infect Dis 2015; 34: 1647-55.
8. Sheng ZK, Hu F, Wang W et al. Mechanisms of tigecycline resistance among Klebsiella pneumoniae clinical isolates. Antimicrob Agents Chemother 2014; 58: 6982-5.
9. Cannatelli A, Giani T, D'Andrea MM et al. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother 2014; 58: 5696-703.
10. Siguier P, Perochon J, Lestrade L et al. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res 2006; 34: D32-6.
11. Kontopidou F, Giamarellou H, Katerelos P et al. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect 2014; 20: O117-23.
12. Bonura C, Giuffre M, Aleo A et al. An update of the evolving epidemic of blaKPC carrying Klebsiella pneumoniae in Sicily, Italy, 2014: emergence of multiple non-ST258 clones. PLoS One 2015; 10: e0132936.
13. Monaco M, Giani T, Raffone M et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 2014; 19: pii=20939.
14. Olaitan AO, Diene SM, Kempf M et al. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents 2014; 44: 500-7.
15. Horiyama T, Nikaido E, Yamaguchi A et al. Roles of Salmonella multidrug efflux pumps in tigecycline resistance. J Antimicrob Chemother 2011; 66: 105-10.
16. Villa L, Feudi C, Fortini D et al. Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance. Antimicrob Agents Chemother 2014; 58: 1707-12.
17. Bialek-Davenet S, Criscuolo A, Ailloud F et al. Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg Infect Dis 2014; 20: 1812-20.